We are studying whether MDMA-assisted psychotherapy can help heal the psychological and emotional damage caused by sexual assault, war, violent crime, and other traumas. We are also studying MDMA-assisted therapy for autistic adults with social anxiety and MDMA-assisted psychotherapy for people with anxiety related to life-threatening illnesses.
Our highest priority project is funding clinical trials of 3,4-methylenedioxymethamphetamine (MDMA) as a tool to assist psychotherapy for the treatment of posttraumatic stress disorder (PTSD). Preliminary studies have shown that MDMA in conjunction with psychotherapy can help people overcome PTSD, and possibly other disorders as well. MDMA is known for increasing feelings of trust and compassion towards others, which could make an ideal adjunct to psychotherapy for PTSD.
Watch: CNN with Sanjay Gupta, MD: September 15, 2014
In MDMA-assisted psychotherapy, MDMA is only administered a few times, unlike most medications for mental illnesses which are often taken daily for years, and sometimes forever.
MDMA is not the same as "Ecstasy" or "molly." Substances sold on the street under these names may contain MDMA, but frequently also contain unknown and/or dangerous adulterants. In laboratory studies, pure MDMA has been proven sufficiently safe for human consumption when taken a limited number of times in moderate doses.
MAPS is undertaking a roughly $20 million plan to make MDMA into a Food and Drug Administration (FDA)-approved prescription medicine by 2021, and is currently the only organization in the world funding clinical trials of MDMA-assisted psychotherapy. For-profit pharmaceutical companies are not interested in developing MDMA into a medicine because the patent for MDMA has expired. The idea of using MDMA to assist psychotherapy of any kind for any specific clinical indication has long been in the public domain.
Download our brochure.
Explore MAPS in the Media for the latest headlines.
Learn about MDMA-assisted therapy for social anxiety in autistic adults at mdma-autism.org.
MDMA-Assisted Psychotherapy for PTSD: MAPS-Sponsored Clinical Trials
- U.S. Veterans Study (Charleston, South Carolina)
- U.S. Veterans Study Timeline
- U.S. Boulder Study (Boulder, Colorado)
- U.S. Boulder Study Timeline
- Canadian Study (Vancouver, BC)
- Canadian Study Timeline
- Israeli Study (Beer Yaakov, Israel)
- Israeli Study Timeline
- U.S. Therapist Training Study (Charleston, South Carolina)
- U.S. Therapist Training Study Timeline